S&P 500

6.040,53

-0,50%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NYSE
Bausch plus Lomb Corporation (BLCO)
Bausch plus Lomb Corporation (BLCO) Notícias

BLCO

Bausch plus Lomb (BLCO)

Bausch plus Lomb Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:BLCO

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
22/01/2025	09:00	Business Wire	Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19	NYSE:BLCO	Bausch plus Lomb Corporation
13/01/2025	09:00	Business Wire	Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences	NYSE:BLCO	Bausch plus Lomb Corporation
13/01/2025	08:00	Business Wire	Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union	NYSE:BLCO	Bausch plus Lomb Corporation
07/01/2025	09:00	Business Wire	Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge	NYSE:BLCO	Bausch plus Lomb Corporation
02/01/2025	09:00	Business Wire	Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference	NYSE:BLCO	Bausch plus Lomb Corporation
26/12/2024	18:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
12/12/2024	09:00	Business Wire	Bausch + Lomb Responds to Rumors of a Potential Sale	NYSE:BLCO	Bausch plus Lomb Corporation
11/12/2024	08:59	Business Wire	Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities	NYSE:BLCO	Bausch plus Lomb Corporation
14/11/2024	09:00	Business Wire	Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs	NYSE:BLCO	Bausch plus Lomb Corporation
01/11/2024	17:27	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BLCO	Bausch plus Lomb Corporation
30/10/2024	17:32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:BLCO	Bausch plus Lomb Corporation
30/10/2024	08:00	Business Wire	Bausch + Lomb Announces Third-Quarter 2024 Results	NYSE:BLCO	Bausch plus Lomb Corporation
14/10/2024	08:00	Business Wire	Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens	NYSE:BLCO	Bausch plus Lomb Corporation
09/10/2024	09:00	Business Wire	Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30	NYSE:BLCO	Bausch plus Lomb Corporation
01/10/2024	08:00	Business Wire	Bausch + Lomb Launches Opal™ Digital Marketplace in the United States	NYSE:BLCO	Bausch plus Lomb Corporation
17/09/2024	07:42	IH Market News	Investors Anticipate Retail Sales Data and Fed Decision; Oil Prices Dip as Investors Weigh U.S. Production	NYSE:BLCO	Bausch plus Lomb Corporation
01/08/2024	17:48	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:BLCO	Bausch plus Lomb Corporation
31/07/2024	08:00	Business Wire	Bausch + Lomb Announces Second-Quarter 2024 Results	NYSE:BLCO	Bausch plus Lomb Corporation
11/07/2024	13:05	Business Wire	Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31	NYSE:BLCO	Bausch plus Lomb Corporation
08/07/2024	08:00	Business Wire	Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief	NYSE:BLCO	Bausch plus Lomb Corporation
17/06/2024	08:00	Business Wire	Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress	NYSE:BLCO	Bausch plus Lomb Corporation
10/06/2024	08:00	Business Wire	Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States	NYSE:BLCO	Bausch plus Lomb Corporation
03/06/2024	08:00	Business Wire	Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States	NYSE:BLCO	Bausch plus Lomb Corporation
29/05/2024	17:30	Business Wire	Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results	NYSE:BLCO	Bausch plus Lomb Corporation
28/05/2024	10:00	Business Wire	Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®	NYSE:BLCO	Bausch plus Lomb Corporation
28/05/2024	07:59	Business Wire	Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens	NYSE:BLCO	Bausch plus Lomb Corporation
07/05/2024	10:09	IH Market News	Futures Pointing To Roughly Flat Open On Wall Street	NYSE:BLCO	Bausch plus Lomb Corporation
06/05/2024	17:34	IH Market News	U.S. Stocks See Further Upside Amid Renewed Interest Rate Optimism	NYSE:BLCO	Bausch plus Lomb Corporation
01/05/2024	07:58	Business Wire	Bausch + Lomb Announces First-Quarter 2024 Results	NYSE:BLCO	Bausch plus Lomb Corporation
29/04/2024	08:00	Business Wire	Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting	NYSE:BLCO	Bausch plus Lomb Corporation